Wednesday, 29 September 2010
K2 Pedia! | Seattle Genetics And Millennium Announce Positive Top-Line Brentuximab Vedotin Data From Pivotal Trial In Relapsed And Refractory Hodgkin Lymphoma | Pivotal, Brentuximab, Trial, Company, Takeda, Topline, Vedotin, Genetics, Seattle, Positive, Millennium, Announced, Results, Singleagent, http://www.k2pedia.com/blood/90734-seattle-genetics-and-millennium-announce-positive-top-line-brentuximab-vedotin-data-from-pivotal-trial-in-relapsed-and-refractory-hodgkin-lymphoma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment